English
简体中文
Total: £ 56.28
Published Date: 2025-04-01 | Pages: 84 | Tables: 83 | Medical Care
The global market for Decentralized Clinical Trials (DCTs) was valued at US$ 9384 million in the year 2024 and is projected to reach a revised size of US$ 24340 million by 2031, growing at a CAGR of 14.8% during the forecast period.
The FDA defines decentralized clinical trials as those executed through telemedicine and mobile or local healthcare providers, using processes and technologies that differ from the traditional clinical trial model. Decentralized clinical trials are conducted remotely, with patient subjects remaining at home during a significant portion, or all, of the study. However, the decentralized clinical trial model is designed for more just patient participants.
The decentralized clinical trials (DCT) market is driven by the growing need for patient-centric trial designs that improve accessibility and convenience. By leveraging technology such as telemedicine, wearables, and remote monitoring, DCTs allow patients to participate from their homes, reducing the burden of travel and time commitments. This not only enhances patient recruitment and retention rates but also enables trials to include more diverse and geographically dispersed populations, ultimately accelerating the drug development process. However, a significant challenge in the decentralized clinical trials market is the integration of complex digital tools and data management systems. Ensuring the seamless and secure transfer of patient data across various platforms requires significant investment in infrastructure and poses privacy concerns. Additionally, regulatory frameworks for DCTs are still evolving, and inconsistencies in approval processes across regions can create barriers for global trial implementation. Ensuring patient compliance and maintaining trial integrity in a remote setting also add layers of complexity to trial management.
Global Decentralized Clinical Trials (DCTs) key players include Medidata, IQVIA, Labcorp, PRA Health Sciences, Parexel, etc. Global top five manufacturers hold a share over 45%. North America is the largest sales region, with a share about 60%, followed by Europe and Asia-Pacific, both have a share over 30 percent. In terms of product, Interventional is the largest segment, with a share over 45%. And in terms of application, the largest application is Oncology, followed by Cardiovascular, etc.
This report aims to provide a comprehensive presentation of the global market for Decentralized Clinical Trials (DCTs), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Decentralized Clinical Trials (DCTs).
The Decentralized Clinical Trials (DCTs) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Decentralized Clinical Trials (DCTs) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Decentralized Clinical Trials (DCTs) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Medidata
IQVIA
Labcorp
PRA Health Sciences
Parexel
ICON
Oracle
CRF Health
Clinical Ink
Medable
Science 37
Segment by Type
Interventional
Observational
Expanded Access
Segment by Application
Oncology
Cardiovascular
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Decentralized Clinical Trials (DCTs) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Decentralized Clinical Trials (DCTs) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Interventional
1.2.3 Observational
1.2.4 Expanded Access
1.3 Market by Application
1.3.1 Global Decentralized Clinical Trials (DCTs) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oncology
1.3.3 Cardiovascular
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Decentralized Clinical Trials (DCTs) Market Perspective (2020-2031)
2.2 Global Decentralized Clinical Trials (DCTs) Growth Trends by Region
2.2.1 Global Decentralized Clinical Trials (DCTs) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Decentralized Clinical Trials (DCTs) Historic Market Size by Region (2020-2025)
2.2.3 Decentralized Clinical Trials (DCTs) Forecasted Market Size by Region (2026-2031)
2.3 Decentralized Clinical Trials (DCTs) Market Dynamics
2.3.1 Decentralized Clinical Trials (DCTs) Industry Trends
2.3.2 Decentralized Clinical Trials (DCTs) Market Drivers
2.3.3 Decentralized Clinical Trials (DCTs) Market Challenges
2.3.4 Decentralized Clinical Trials (DCTs) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Decentralized Clinical Trials (DCTs) Players by Revenue
3.1.1 Global Top Decentralized Clinical Trials (DCTs) Players by Revenue (2020-2025)
3.1.2 Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Players (2020-2025)
3.2 Global Decentralized Clinical Trials (DCTs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Decentralized Clinical Trials (DCTs) Revenue
3.4 Global Decentralized Clinical Trials (DCTs) Market Concentration Ratio
3.4.1 Global Decentralized Clinical Trials (DCTs) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Decentralized Clinical Trials (DCTs) Revenue in 2024
3.5 Global Key Players of Decentralized Clinical Trials (DCTs) Head office and Area Served
3.6 Global Key Players of Decentralized Clinical Trials (DCTs), Product and Application
3.7 Global Key Players of Decentralized Clinical Trials (DCTs), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Decentralized Clinical Trials (DCTs) Breakdown Data by Type
4.1 Global Decentralized Clinical Trials (DCTs) Historic Market Size by Type (2020-2025)
4.2 Global Decentralized Clinical Trials (DCTs) Forecasted Market Size by Type (2026-2031)
5 Decentralized Clinical Trials (DCTs) Breakdown Data by Application
5.1 Global Decentralized Clinical Trials (DCTs) Historic Market Size by Application (2020-2025)
5.2 Global Decentralized Clinical Trials (DCTs) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Decentralized Clinical Trials (DCTs) Market Size (2020-2031)
6.2 North America Decentralized Clinical Trials (DCTs) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Decentralized Clinical Trials (DCTs) Market Size by Country (2020-2025)
6.4 North America Decentralized Clinical Trials (DCTs) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Decentralized Clinical Trials (DCTs) Market Size (2020-2031)
7.2 Europe Decentralized Clinical Trials (DCTs) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Decentralized Clinical Trials (DCTs) Market Size by Country (2020-2025)
7.4 Europe Decentralized Clinical Trials (DCTs) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size (2020-2031)
8.2 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Region (2020-2025)
8.4 Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Decentralized Clinical Trials (DCTs) Market Size (2020-2031)
9.2 Latin America Decentralized Clinical Trials (DCTs) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Decentralized Clinical Trials (DCTs) Market Size by Country (2020-2025)
9.4 Latin America Decentralized Clinical Trials (DCTs) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size (2020-2031)
10.2 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Country (2020-2025)
10.4 Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medidata
11.1.1 Medidata Company Details
11.1.2 Medidata Business Overview
11.1.3 Medidata Decentralized Clinical Trials (DCTs) Introduction
11.1.4 Medidata Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025)
11.1.5 Medidata Recent Development
11.2 IQVIA
11.2.1 IQVIA Company Details
11.2.2 IQVIA Business Overview
11.2.3 IQVIA Decentralized Clinical Trials (DCTs) Introduction
11.2.4 IQVIA Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025)
11.2.5 IQVIA Recent Development
11.3 Labcorp
11.3.1 Labcorp Company Details
11.3.2 Labcorp Business Overview
11.3.3 Labcorp Decentralized Clinical Trials (DCTs) Introduction
11.3.4 Labcorp Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025)
11.3.5 Labcorp Recent Development
11.4 PRA Health Sciences
11.4.1 PRA Health Sciences Company Details
11.4.2 PRA Health Sciences Business Overview
11.4.3 PRA Health Sciences Decentralized Clinical Trials (DCTs) Introduction
11.4.4 PRA Health Sciences Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025)
11.4.5 PRA Health Sciences Recent Development
11.5 Parexel
11.5.1 Parexel Company Details
11.5.2 Parexel Business Overview
11.5.3 Parexel Decentralized Clinical Trials (DCTs) Introduction
11.5.4 Parexel Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025)
11.5.5 Parexel Recent Development
11.6 ICON
11.6.1 ICON Company Details
11.6.2 ICON Business Overview
11.6.3 ICON Decentralized Clinical Trials (DCTs) Introduction
11.6.4 ICON Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025)
11.6.5 ICON Recent Development
11.7 Oracle
11.7.1 Oracle Company Details
11.7.2 Oracle Business Overview
11.7.3 Oracle Decentralized Clinical Trials (DCTs) Introduction
11.7.4 Oracle Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025)
11.7.5 Oracle Recent Development
11.8 CRF Health
11.8.1 CRF Health Company Details
11.8.2 CRF Health Business Overview
11.8.3 CRF Health Decentralized Clinical Trials (DCTs) Introduction
11.8.4 CRF Health Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025)
11.8.5 CRF Health Recent Development
11.9 Clinical Ink
11.9.1 Clinical Ink Company Details
11.9.2 Clinical Ink Business Overview
11.9.3 Clinical Ink Decentralized Clinical Trials (DCTs) Introduction
11.9.4 Clinical Ink Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025)
11.9.5 Clinical Ink Recent Development
11.10 Medable
11.10.1 Medable Company Details
11.10.2 Medable Business Overview
11.10.3 Medable Decentralized Clinical Trials (DCTs) Introduction
11.10.4 Medable Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025)
11.10.5 Medable Recent Development
11.11 Science 37
11.11.1 Science 37 Company Details
11.11.2 Science 37 Business Overview
11.11.3 Science 37 Decentralized Clinical Trials (DCTs) Introduction
11.11.4 Science 37 Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025)
11.11.5 Science 37 Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Decentralized Clinical Trials (DCTs) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Interventional
Table 3. Key Players of Observational
Table 4. Key Players of Expanded Access
Table 5. Global Decentralized Clinical Trials (DCTs) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Decentralized Clinical Trials (DCTs) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Decentralized Clinical Trials (DCTs) Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Decentralized Clinical Trials (DCTs) Market Share by Region (2020-2025)
Table 9. Global Decentralized Clinical Trials (DCTs) Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Decentralized Clinical Trials (DCTs) Market Share by Region (2026-2031)
Table 11. Decentralized Clinical Trials (DCTs) Market Trends
Table 12. Decentralized Clinical Trials (DCTs) Market Drivers
Table 13. Decentralized Clinical Trials (DCTs) Market Challenges
Table 14. Decentralized Clinical Trials (DCTs) Market Restraints
Table 15. Global Decentralized Clinical Trials (DCTs) Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Decentralized Clinical Trials (DCTs) Market Share by Players (2020-2025)
Table 17. Global Top Decentralized Clinical Trials (DCTs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Decentralized Clinical Trials (DCTs) as of 2024)
Table 18. Ranking of Global Top Decentralized Clinical Trials (DCTs) Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Decentralized Clinical Trials (DCTs) Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Decentralized Clinical Trials (DCTs), Headquarters and Area Served
Table 21. Global Key Players of Decentralized Clinical Trials (DCTs), Product and Application
Table 22. Global Key Players of Decentralized Clinical Trials (DCTs), Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Decentralized Clinical Trials (DCTs) Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Type (2020-2025)
Table 26. Global Decentralized Clinical Trials (DCTs) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Type (2026-2031)
Table 28. Global Decentralized Clinical Trials (DCTs) Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Application (2020-2025)
Table 30. Global Decentralized Clinical Trials (DCTs) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Decentralized Clinical Trials (DCTs) Revenue Market Share by Application (2026-2031)
Table 32. North America Decentralized Clinical Trials (DCTs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Decentralized Clinical Trials (DCTs) Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Decentralized Clinical Trials (DCTs) Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Decentralized Clinical Trials (DCTs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Decentralized Clinical Trials (DCTs) Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Decentralized Clinical Trials (DCTs) Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Decentralized Clinical Trials (DCTs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Decentralized Clinical Trials (DCTs) Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Decentralized Clinical Trials (DCTs) Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size by Country (2026-2031) & (US$ Million)
Table 47. Medidata Company Details
Table 48. Medidata Business Overview
Table 49. Medidata Decentralized Clinical Trials (DCTs) Product
Table 50. Medidata Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025) & (US$ Million)
Table 51. Medidata Recent Development
Table 52. IQVIA Company Details
Table 53. IQVIA Business Overview
Table 54. IQVIA Decentralized Clinical Trials (DCTs) Product
Table 55. IQVIA Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025) & (US$ Million)
Table 56. IQVIA Recent Development
Table 57. Labcorp Company Details
Table 58. Labcorp Business Overview
Table 59. Labcorp Decentralized Clinical Trials (DCTs) Product
Table 60. Labcorp Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025) & (US$ Million)
Table 61. Labcorp Recent Development
Table 62. PRA Health Sciences Company Details
Table 63. PRA Health Sciences Business Overview
Table 64. PRA Health Sciences Decentralized Clinical Trials (DCTs) Product
Table 65. PRA Health Sciences Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025) & (US$ Million)
Table 66. PRA Health Sciences Recent Development
Table 67. Parexel Company Details
Table 68. Parexel Business Overview
Table 69. Parexel Decentralized Clinical Trials (DCTs) Product
Table 70. Parexel Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025) & (US$ Million)
Table 71. Parexel Recent Development
Table 72. ICON Company Details
Table 73. ICON Business Overview
Table 74. ICON Decentralized Clinical Trials (DCTs) Product
Table 75. ICON Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025) & (US$ Million)
Table 76. ICON Recent Development
Table 77. Oracle Company Details
Table 78. Oracle Business Overview
Table 79. Oracle Decentralized Clinical Trials (DCTs) Product
Table 80. Oracle Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025) & (US$ Million)
Table 81. Oracle Recent Development
Table 82. CRF Health Company Details
Table 83. CRF Health Business Overview
Table 84. CRF Health Decentralized Clinical Trials (DCTs) Product
Table 85. CRF Health Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025) & (US$ Million)
Table 86. CRF Health Recent Development
Table 87. Clinical Ink Company Details
Table 88. Clinical Ink Business Overview
Table 89. Clinical Ink Decentralized Clinical Trials (DCTs) Product
Table 90. Clinical Ink Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025) & (US$ Million)
Table 91. Clinical Ink Recent Development
Table 92. Medable Company Details
Table 93. Medable Business Overview
Table 94. Medable Decentralized Clinical Trials (DCTs) Product
Table 95. Medable Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025) & (US$ Million)
Table 96. Medable Recent Development
Table 97. Science 37 Company Details
Table 98. Science 37 Business Overview
Table 99. Science 37 Decentralized Clinical Trials (DCTs) Product
Table 100. Science 37 Revenue in Decentralized Clinical Trials (DCTs) Business (2020-2025) & (US$ Million)
Table 101. Science 37 Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
Table 105. Authors List of This Report
List of Figures
Figure 1. Decentralized Clinical Trials (DCTs) Picture
Figure 2. Global Decentralized Clinical Trials (DCTs) Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Decentralized Clinical Trials (DCTs) Market Share by Type: 2024 VS 2031
Figure 4. Interventional Features
Figure 5. Observational Features
Figure 6. Expanded Access Features
Figure 7. Global Decentralized Clinical Trials (DCTs) Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Decentralized Clinical Trials (DCTs) Market Share by Application: 2024 VS 2031
Figure 9. Oncology Case Studies
Figure 10. Cardiovascular Case Studies
Figure 11. Others Case Studies
Figure 12. Decentralized Clinical Trials (DCTs) Report Years Considered
Figure 13. Global Decentralized Clinical Trials (DCTs) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Decentralized Clinical Trials (DCTs) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Decentralized Clinical Trials (DCTs) Market Share by Region: 2024 VS 2031
Figure 16. Global Decentralized Clinical Trials (DCTs) Market Share by Players in 2024
Figure 17. Global Top Decentralized Clinical Trials (DCTs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Decentralized Clinical Trials (DCTs) as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Decentralized Clinical Trials (DCTs) Revenue in 2024
Figure 19. North America Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Decentralized Clinical Trials (DCTs) Market Share by Country (2020-2031)
Figure 21. United States Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Decentralized Clinical Trials (DCTs) Market Share by Country (2020-2031)
Figure 25. Germany Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Decentralized Clinical Trials (DCTs) Market Share by Region (2020-2031)
Figure 33. China Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Decentralized Clinical Trials (DCTs) Market Share by Country (2020-2031)
Figure 41. Mexico Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Decentralized Clinical Trials (DCTs) Market Share by Country (2020-2031)
Figure 45. Turkey Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Decentralized Clinical Trials (DCTs) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Medidata Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2020-2025)
Figure 49. IQVIA Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2020-2025)
Figure 50. Labcorp Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2020-2025)
Figure 51. PRA Health Sciences Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2020-2025)
Figure 52. Parexel Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2020-2025)
Figure 53. ICON Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2020-2025)
Figure 54. Oracle Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2020-2025)
Figure 55. CRF Health Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2020-2025)
Figure 56. Clinical Ink Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2020-2025)
Figure 57. Medable Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2020-2025)
Figure 58. Science 37 Revenue Growth Rate in Decentralized Clinical Trials (DCTs) Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
